Initial Treatment for Acute Congestive Heart Failure

First-Line Interventions

• The European Society of Cardiology recommends initial treatment for acute congestive heart failure should include intravenous diuretics, oxygen therapy, and vasodilators for patients with adequate blood pressure 1, 2
• Provide oxygen therapy with face mask or CPAP (target SpO2 94-96%) 3
• Non-invasive positive pressure ventilation reduces respiratory distress and may decrease intubation and mortality rates in patients with respiratory distress 1
• Continue non-invasive ventilation upon hospital arrival if respiratory distress persists, preferably PS-PEEP for patients with acidosis and hypercapnia 2

Diuretic Therapy

• Administer IV furosemide as the cornerstone of initial treatment, with a dose of 20-40 mg IV for diuretic-naïve patients or at least equivalent to oral dose for those on chronic therapy 1, 2
• Diuretics can be given either as intermittent boluses or continuous infusion, with dose and duration adjusted according to symptoms and clinical status 1, 2

Vasodilator Therapy

• IV vasodilators should be considered for symptomatic relief in AHF with SBP >90 mmHg (without symptomatic hypotension) 1, 2
• In hypertensive AHF, IV vasodilators should be considered as initial therapy to improve symptoms and reduce congestion 2

Special Considerations Based on Clinical Presentation

• For patients with hypotension (SBP <90 mmHg), short-term IV infusion of inotropic agents may be considered, but with caution due to safety concerns 2
• For patients with severe dyspnea, consider cautious use of opiates to relieve dyspnea and anxiety, but be aware of potential side effects 2, 3

Monitoring Requirements

• Regular monitoring of symptoms, urine output, renal function, and electrolytes during IV diuretic therapy is recommended 1, 2
• Monitor ECG and blood pressure when using inotropic agents and vasopressors due to risk of arrhythmias, myocardial ischemia, and hypotension 2

Additional Measures

• Thromboembolic prophylaxis is recommended in patients not already anticoagulated and with no contraindication to anticoagulation 2
• For diuretic resistance, consider combination therapy with loop diuretic plus either thiazide-type diuretic or spironolactone 2

Common Pitfalls to Avoid

• Using inotropic agents in patients without hypotension or hypoperfusion increases mortality risk 2
• High doses of diuretics may lead to hypovolemia, hyponatremia, and increase the likelihood of hypotension when initiating ACE inhibitors or ARBs 4

Initial Management of Acute Decompensated Heart Failure

General Principles

• The American Heart Association recommends that all ADHF presentations require the same hemodynamic-based approach: fluid removal via diuretics, blood pressure support if needed, and maintenance of guideline-directed medical therapy unless contraindicated 5
• The underlying cause of heart failure (ischemic vs. non-ischemic dilated cardiomyopathy) matters for long-term management but not for acute stabilization 5

Diuretic Therapy

• For patients already on chronic oral loop diuretics, the American College of Cardiology recommends giving IV furosemide at a dose equal to or greater than their total daily oral dose 5
• IV vasodilators (nitroglycerin, nitroprusside, or nesiritide) may be considered for symptomatic relief, particularly in hypertensive ADHF 5

Monitoring and Adjunctive Therapies

• The American Heart Association recommends monitoring hourly urine output initially, daily weights, and daily electrolytes (especially potassium), BUN, creatinine during active IV diuresis 5
• Thromboembolic prophylaxis is recommended for all hospitalized patients unless already anticoagulated or contraindicated 5

Guideline-Directed Medical Therapy

• The American College of Cardiology recommends continuing ACE inhibitors/ARBs and beta-blockers during hospitalization unless hemodynamically unstable 5
• These medications work synergistically with diuretics, and should only be held if SBP <90 mmHg with end-organ dysfunction 5

Acute Decompensated Heart Failure Management

Initial Assessment and Treatment

• The European Society of Cardiology recommends triage to ICU/CCU if respiratory rate >25 breaths/min, SaO2 <90%, use of accessory muscles for breathing, systolic BP <90 mmHg, need for intubation, or signs of hypoperfusion (oliguria, cold peripheries, altered mental status, lactate >2 mmol/L) 6
• High-risk patients with BUN ≥43 mg/dL, systolic BP <115 mmHg, or creatinine ≥2.75 mg/dL should be directed to intensive monitoring environments, as recommended by the European Society of Cardiology 6
• Patients with acute coronary syndrome should be referred to CCU, according to the European Society of Cardiology 6

Pharmacologic Interventions

• The American Heart Association recommends that for patients already on chronic oral loop diuretics, the initial IV dose must equal or exceed their total daily oral dose 7
• The American Heart Association suggests administering IV loop diuretics as either intermittent boluses or continuous infusion, adjusting based on urine output and symptom relief 7
• The European Society of Cardiology recommends monitoring urine output hourly initially and assessing signs of congestion serially 7
• Daily weights (target 0.5-1.0 kg loss daily) and daily electrolytes (especially potassium), BUN, and creatinine should be monitored, as recommended by the European Society of Cardiology and the American Heart Association 6, 7

Monitoring and Supportive Care

• The European Society of Cardiology recommends standard non-invasive monitoring for all patients, including blood pressure, temperature, respiratory rate, heart rate continuously 8, 9, 10
• The European Society of Cardiology suggests ECG monitoring for arrhythmias and ST-segment changes, particularly if ischemia or arrhythmia triggered the acute event 8, 9, 10
• Daily weights and accurate fluid balance charts should be maintained, as recommended by the European Society of Cardiology 6
• The American Heart Association recommends venous thromboembolism prophylaxis with anticoagulation if risk-benefit ratio favorable 7

Discharge Criteria

• The European Society of Cardiology recommends that patients are medically fit for discharge when hemodynamically stable and euvolemic 6
• The European Society of Cardiology suggests that patients should be established on evidence-based guideline-directed medical therapy before discharge 6
• Follow-up should be arranged within 7-14 days with telephone follow-up within 3 days, as recommended by the American Heart Association 7